Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Nelabin 250mg Injection
Manufacturer/Marketed By : MSN LABORATORIES (INDIA)
$130.68 $107.33
Nelabin 250mg Injection contains nelarabine as its active constituent, classified under antineoplastic agents. It is primarily used in the treatment of certain types of blood cancers, specifically T-cell acute lymphoblastic...
NELARABINE
Active Pharmaceutical Ingredient
Nelabin 250mg Injection
$130.68
$107.33
Nelabin 250mg Injection contains nelarabine as its active constituent, classified under antineoplastic agents. It is primarily used in the treatment of certain types of blood cancers, specifically T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). This medication works by disrupting cancer cell growth, ultimately leading to their destruction. As a chemotherapy drug, it is prescribed under strict medical supervision due to its potent effects and potential side effects. Before starting treatment, patients must be evaluated for pre-existing health conditions, including liver and kidney function, neurological status, and blood cell counts. It is not recommended for individuals with severe neurological disorders or those who have previously exhibited hypersensitivity to its components. Special caution is required for pregnant and breastfeeding women, as the drug may cause serious harm to the fetus or infant. Patients should adhere to safety measures to minimise adverse effects and ensure optimal therapeutic outcomes.
Active Pharmaceutical Ingredient
Uses
• T-cell acute lymphoblastic leukemia (T-ALL)
• T-cell lymphoblastic lymphoma (T-LBL)
Benefits
This medication belongs to the class of antimetabolites and acts by interfering with DNA synthesis within rapidly dividing cancer cells. Once inside the body, it is converted into its active form, which integrates into the DNA of malignant cells, disrupting their ability to multiply. This ultimately leads to cell death and reduces the progression of the disease. Due to its targeted mechanism, it is highly effective in treating specific blood malignancies while requiring careful monitoring to manage its associated risks.
Side Effects
Common Side Effects:
Most Common Side Effects
• Severe bone marrow suppression
• Peripheral neuropathy (tingling, numbness, or weakness in limbs)
• Severe infections due to low white blood cell count
• Cognitive and coordination impairments
• Seizures (in rare cases)
Common Side Effects
• Fatigue
• Nausea and vomiting
• Decreased appetite
• Fever
• Muscle weakness
How To Use
Nelabin 250mg Injection is available as an intravenous (IV) infusion and is administered by a healthcare professional in a clinical setting. The dosage is carefully determined based on the patient’s body surface area, overall health status, and response to treatment. It is typically given in cycles, allowing for adequate intervals between doses to enable the body to recover and minimise potential side effects.
Safety Advice
• Breast Feeding: Nelabin 250mg Injection is not recommended due to the risk of serious infant complications.
• Alcohol: Alcohol consumption can worsen side effects and should be avoided if you are taking Nelabin 250mg Injection.
• Liver: Dose adjustments may be needed for individuals with hepatic impairment. Consult a doctor for more advice before taking Nelabin 250mg Injection.
• Lungs: Patients with pre-existing lung conditions should be monitored for respiratory complications before taking Nelabin 250mg Injection.
• Driving: Nelabin 250mg Injection may cause drowsiness, dizziness, or neurological issues, affecting the ability to operate machinery.
• Pregnancy: Nelabin 250mg Injection may cause fetal harm; effective contraception is required during treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.